查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564084

全球全玻片成像市场

Whole Slide Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球全玻片成像市场预计将达到 29 亿美元

2023年全球全玻片成像市场估计为8.907亿美元，预计到2030年将达到29亿美元，2023年至2030年复合年增长率为18.3%。全幻灯片成像硬体是本报告分析的细分市场之一，预计复合年增长率为 18.9%，到分析期结束时将达到 15 亿美元。在分析期间，整个幻灯片成像软体领域的复合年增长率预计为 17.8%。

美国市场预估为2.415亿美元，中国预期复合年增长率为16.9%

到 2023 年，美国整体幻灯片成像市场预计将达到 2.415 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到4.246亿美元，2023-2030年分析期间复合年增长率为16.9%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 16.5% 和 15.6%。在欧洲，德国的复合年增长率预计约为 13.0%。

全球幻灯片成像市场 - 主要趋势和驱动因素总结

为什么全玻片成像会改变病理学和诊断业务？

全切片成像 (WSI) 透过实现整个组织切片的数位化以及高解析度检查、储存和共用病理切片，正在彻底改变病理学和诊断领域。该技术促进远距会诊、数位存檔和人工智慧主导的分析，以提高肿瘤学、血液学和感染疾病的诊断准确性和效率。由于改进诊断工作流程、远端病理学和人工智慧整合的需求，数位病理学的日益普及正在推动对 WSI 系统的需求。随着个人化医疗的兴起以及对准确和可重复诊断资料的需求，WSI 正在成为现代医疗保健的重要工具。

科技进步如何增强整个幻灯片成像系统？

成像硬体、资料管理和人工智慧的技术进步大大提高了全切片成像系统的功能和应用。具有更高解析度和焦深的更快扫描仪的发展使得组织形态和病理学的可视化更加准确和详细。资料压缩和云端储存解决方案的创新正在改善大型影像资料集的处理、储存和搜寻，促进病理实验室的无缝数位工作流程。此外，人工智慧和机器学习演算法的整合可以实现自动影像分析、模式识别和预测诊断，减少病理学家的工作量并提高诊断准确性。这些进步正在推动 WSI 在临床诊断、研究和教育中的采用。

整个幻灯片成像市场面临哪些挑战与机会？

整个幻灯片成像市场面临多项挑战，包括WSI系统的高初始成本、资料管理的复杂性以及数位病理平台之间标准化和互通性的需求。此外，监管障碍和临床使用数位病理系统检验的需求可能会减缓采用速度。但这些挑战也带来了成长和创新的机会。开发具有成本效益且扩充性的WSI 解决方案，提供高品质的影像、与现有实验室基础设施的轻鬆整合以及强大的资料管理功能，将推动临床和研究环境的采用。对第二意见和专家知识的需求正在推动对远端病理学和远距离诊断的需求，为支援无缝数位咨询和协作的 WSI 系统创造新的成长机会。此外，对人工智慧主导的诊断和精准医疗的日益关注正在推动对先进 WSI 解决方案的需求，这些解决方案可为临床决策提供可靠且可重复的资料。

整个幻灯片成像市场成长的驱动力是什么？

整个幻灯片成像市场的成长也受到多种因素的推动，例如数位病理学的日益普及、对远端病理诊断和远距离诊断的需求不断增长，以及成像硬体、资料管理和人工智慧主导分析的技术进步。应用。病理诊断中对提高诊断准确性、效率和协作的需求正在显着推动临床和研究环境中对 WSI 系统的市场需求。高解析度成像、云端储存和基于人工智慧的分析方面的创新正在提高 WSI 系统的功能和扩充性，使其对医院、研究机构和诊断实验室更具吸引力。此外，个人化医疗的扩展和对数位医疗转型的日益重视也推动了市场成长，因为相关人员寻求先进的数位病理工具来改善诊断工作流程和病患治疗结果。

受访企业范例（47家知名企业）

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP15632

Global Whole Slide Imaging Market to Reach US$2.9 Billion by 2030

The global market for Whole Slide Imaging estimated at US$890.7 Million in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2023-2030. Whole Slide Imaging Hardware, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Whole Slide Imaging Software segment is estimated at 17.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.5 Million While China is Forecast to Grow at 16.9% CAGR

The Whole Slide Imaging market in the U.S. is estimated at US$241.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$424.6 Million by the year 2030 trailing a CAGR of 16.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Whole Slide Imaging Market - Key Trends & Drivers Summarized

Why Is Whole Slide Imaging Transforming Pathology and Diagnostic Practices?

Whole Slide Imaging (WSI) is revolutionizing the field of pathology and diagnostic practices by enabling the digitization of entire histological slides, allowing for high-resolution examination, storage, and sharing of pathology slides. This technology facilitates remote consultations, digital archiving, and AI-driven analysis, enhancing the accuracy and efficiency of diagnostics in oncology, hematology, and infectious diseases. The increasing adoption of digital pathology, driven by the need for improved diagnostic workflows, telepathology, and the integration of artificial intelligence, is propelling the demand for WSI systems. With the rise of personalized medicine and the need for precise and reproducible diagnostic data, WSI is becoming a crucial tool in modern healthcare.

How Are Technological Advancements Enhancing Whole Slide Imaging Systems?

Technological advancements in imaging hardware, data management, and artificial intelligence are significantly enhancing the capabilities and applications of whole slide imaging systems. The development of high-speed scanners with higher resolution and depth of focus is enabling more accurate and detailed visualization of tissue morphology and pathology. Innovations in data compression and cloud storage solutions are improving the handling, storage, and retrieval of large image datasets, facilitating seamless digital workflows in pathology labs. Additionally, the integration of AI and machine learning algorithms is enabling automated image analysis, pattern recognition, and predictive diagnostics, reducing the workload on pathologists and increasing diagnostic accuracy. These advancements are driving the adoption of WSI in clinical diagnostics, research, and education.

What Are the Challenges and Opportunities in the Whole Slide Imaging Market?

The whole slide imaging market faces several challenges, including high initial costs of WSI systems, data management complexities, and the need for standardization and interoperability across digital pathology platforms. Additionally, regulatory hurdles and the need for validation of digital pathology systems for clinical use can slow down adoption. However, these challenges also present opportunities for growth and innovation. The development of cost-effective and scalable WSI solutions that offer high-quality imaging, easy integration with existing lab infrastructure, and robust data management capabilities can help drive adoption in both clinical and research settings. The increasing demand for telepathology and remote diagnostics, driven by the need for second opinions and specialized expertise, is creating new growth opportunities for WSI systems that support seamless digital consultation and collaboration. Moreover, the rising focus on AI-driven diagnostics and precision medicine is driving the need for advanced WSI solutions that provide reliable and reproducible data for clinical decision-making.

What Is Driving the Growth of the Whole Slide Imaging Market?

The growth in the Whole Slide Imaging market is driven by several factors, including the increasing adoption of digital pathology, rising demand for telepathology and remote diagnostics, and technological advancements in imaging hardware, data management, and AI-driven analysis. The need for improved diagnostic accuracy, efficiency, and collaboration in pathology is significantly boosting market demand for WSI systems in clinical and research settings. Technological innovations in high-resolution imaging, cloud storage, and AI-based analytics are enhancing the capabilities and scalability of WSI systems, making them more attractive to hospitals, research institutes, and diagnostic labs. The expansion of personalized medicine and the growing emphasis on digital healthcare transformation are also driving market growth as stakeholders seek advanced digital pathology tools to enhance diagnostic workflows and patient outcomes.

Select Competitors (Total 47 Featured) -

  • 3DHISTECH Ltd.
  • Definiens AG
  • Hamamatsu Photonics KK
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • Leica Microsystems GmbH
  • Mikroscan Technologies, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Ventana Medical Systems, Inc.
  • Visiopharm

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Whole Slide Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Digital Pathology Solutions Drives Whole Slide Imaging Market
    • Technological Advancements in Imaging and Analysis Propel Market Growth
    • Increased Adoption in Clinical Diagnostics Enhances Whole Slide Imaging Utilization
    • Growth in Cancer Research Necessitates Efficient Whole Slide Imaging Solutions
    • Integration of AI and Machine Learning in Image Analysis Expands Capabilities
    • Global Expansion of Telepathology Services Amplifies Whole Slide Imaging Demand
    • Regulatory and Compliance Requirements Influence Whole Slide Imaging Adoption
    • Developments in High-Throughput Scanning Technologies Boost Market Efficiency
    • Rising Healthcare Expenditure Worldwide Sustains Investment in Digital Imaging
    • Technological Convergence in Healthcare IT Systems Promotes Interoperability
    • Data Management and Storage Challenges Drive Solutions in Digital Pathology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Slide Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Telepathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Telepathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cytopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Cytopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hematopathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Hematopathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • JAPAN
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • CHINA
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • EUROPE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Whole Slide Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • FRANCE
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • GERMANY
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • UNITED KINGDOM
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Whole Slide Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by Solution - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Whole Slide Imaging by Solution - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2024 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Slide Imaging by End-Use - Telepathology, Cytopathology, Immunohistochemistry and Hematopathology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Whole Slide Imaging by End-Use - Percentage Breakdown of Value Sales for Telepathology, Cytopathology, Immunohistochemistry and Hematopathology for the Years 2024 & 2030

IV. COMPETITION